Cancer Communications
indexed by SCI
BMC


LETTER TO THE EDITOR
Low cholesterol biosynthesis favors epithelial-to-mesenchymal transition maintenance and influences tumor molecular subtyping and disease-free survival in colon cancer patients
Ana?s Aulas, Maria Lucia Liberatoscioli, Pascal Finetti, Olivier Cabaud, David J. Birnbaum, Lucas Usclade, Daniel Birnbaum, Fran?ois Bertucci, Emilie Mamessier
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/30/2022   doi:10.1002/cac2.12329
ORIGINAL ARTICLE
Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma
Chang Zhang, Qi Sun, Xu Zhang, Na Qin, Zhening Pu, Yayun Gu, Caiwang Yan, Meng Zhu, Juncheng Dai, Cheng Wang, Ni Li, Guangfu Jin, Hongxia Ma, Zhibin Hu, Erbao Zhang, Fengwei Tan, Hongbing Shen
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/21/2022   doi:10.1002/cac2.12325
LETTER TO THE EDITOR
DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines
Zhifu Sun, Xuewei Wang, Pete Vedell, Jean-Pierre Kocher
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/18/2022   doi:10.1002/cac2.12326
ORIGINAL ARTICLE
PDGFA-associated protein 1 is a novel target of c-Myc and contributes to colorectal cancer initiation and progression
Hong-Yong Cui, Wei Wei, Mei-Rui Qian, Ruo-Fei Tian, Xin Fu, Hong-Wei Li, Gang Nan, Ting Yang, Peng Lin, Xi Chen, Yu-Meng Zhu, Bin Wang, Xiu-Xuan Sun, Jian-Hua Dou, Jian-Li Jiang, Ling Li, Shi-Jie Wang, Zhi-Nan Chen
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/18/2022   doi:10.1002/cac2.12322
ORIGINAL ARTICLE
The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death
Liyuan Wu, Fei Liu, Le Yin, Fangming Wang, Hui Shi, Qinxin Zhao, Feiya Yang, Dong Chen, Xiying Dong, Yuchun Gu, Nianzeng Xing
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/15/2022   doi:10.1002/cac2.12321
LETTER TO THE EDITOR
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor-associated myocarditis
Yan Xu, Yanjun Song, Xiaoyan Liu, Yuequan Shi, Yingxian Liu, Hao Qian, Xiaoxing Gao, Minjiang Chen, Ruili Pan, Jing Zhao, Wei Zhong, Wei Wu, Mengzhao Wang
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/9/2022   doi:10.1002/cac2.12320
EDITORIAL
PKCβII–ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity
Guang Lei, Amber Horbath, Zhuang Li, Boyi Gan
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/8/2022   doi:10.1002/cac2.12319
ORIGINAL ARTICLE
Survival trends of patients with non-metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates
Lei Huang, Lina Jansen, Rob H.A. Verhoeven, Jelle P. Ruurda, Liesbet Van Eycken, Harlinde De Schutter, Jan Johansson, Mats Lindblad, Tom B. Johannesen, Vesna Zadnik, Tina ?agar, Sjoerd M. Lagarde, Cornelis J.H. van de Velde, Petra Schrotz-King, Hermann Brenner
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/6/2022   doi:10.1002/cac2.12318
ORIGINAL ARTICLE
Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line
Chaoji Shi, Ziyue Gu, Shengming Xu, Houyu Ju, Yunteng Wu, Yong Han, Jiayi Li, Chuwen Li, Jing Wu, Lizhen Wang, Jiang Li, Guoyu Zhou, Weimin Ye, Guoxin Ren, Zhiyuan Zhang, Rong Zhou
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/4/2022   doi:10.1002/cac2.12315
REVIEW
Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials
Yang Xu, Ping Li, Yang Liu, Dijia Xin, Wen Lei, Aibin Liang, Weidong Han, Wenbin Qian
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 6/1/2022   doi:10.1002/cac2.12313

<<    Page 14 of 62  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China